Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Cancer of the Retina

1-methyl-3-isobutylxanthine has been researched along with Cancer of the Retina in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Remessy, AE1
Rabie, AM1
El-Shishtawy, MM1
Eissa, LA1
Liou, GI1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Cancer of the Retina

ArticleYear
Regulation of interphotoreceptor retinoid-binding protein (IRBP) gene expression by cAMP in differentiated retinoblastoma cells.
    Molecular vision, 2000, Dec-08, Volume: 6

    Topics: 1-Methyl-3-isobutylxanthine; Actins; Blotting, Northern; Cell Differentiation; Colforsin; Cyclic AMP

2000